FinTechsDepot FinTechsDepot - Empowering FinTech Futures: Where Knowledge Fuels Innovation.

  • HOME
  • ARTICLES
    • Digital banking
  • RESOURCES
    • Whitepaper
    • Infographics
  • GLOBENEWSWIRE NEWS
  • EVENTS
    • Upcoming conference
    • Past Conference
    • Webinar
  • Contact Us
FinTechsDepot
  • Home
  • Admin
  • Page 27

Author

Admin 425 posts 0 comments

Webinar

Progress and Challenges to Achieving a Common Taxonomy for Climate Investments

Admin Jun 3, 2025
As countries and governments have pursued policies and regulations to fulfill their commitments to achieve a…
Whitepaper

The Money Revolution Crypto, CBDCs, and the future of finance

Admin Jun 2, 2025
Money has transformed human society, enabling commerce and trade even between widely dispersed geographic…
Featured News

Economic Growth, RBI Reforms, and Strategic Investments

Admin May 30, 2025
India's Q4 FY25 GDP Growth Surpasses Expectations India's economy grew by 7.4% in the January–March 2025…
Articles

The FinTech Revolution: How Technology Is Reshaping Financial Services 

Admin May 29, 2025
The financial world is undergoing a transformative shift powered by digital innovation. What was once a…
Whitepaper

The Future of Closed Loop Cards in Transport

Admin May 28, 2025
Over the past decade, a number of major innovations have been introduced that are transforming transport ticketing…
Featured News

Data Mynt Payment Processing Platform Now Supports Bitcoin Payments

Admin May 27, 2025
Data Mynt, a leading provider of simple, stable cryptocurrency payment products, now enables payments over the…
Upcoming conference

“The Future of Fintech—Innovation, Regulation & Global Trends”

Admin May 26, 2025
📅 Date: June 10, 2025🕒 Time: 3:00 PM – 4:30 PM IST As the financial technology landscape continues to evolve,…
Articles

The Fintech-Banking Fusion: Navigating Risks and Opportunities

Admin May 23, 2025
In recent years, the line between traditional banking and financial technology (fintech) has increasingly…
Whitepaper

Reimagining The Banking Experience with Artificial Intelligence

Admin May 22, 2025
The rapid evolution of technology across all industries is revolutionising customers’ expectations around digital…
Articles

The Importance of Financial Management for Long-Term Planning — And How to Manage…

Admin May 21, 2025
Financial management is not just about tracking income and expenses—it’s the backbone of long-term planning…
Older Posts
Newer Posts

    SUBSCRIBE NOW


    Via Email
    Via Telephone


    I Agree. I would like to share my information with FinTechsDepot & their partners so that I can receive relevant information about products, services, & offers.

    RECENT POST

    • Future of Finance: Review on the outlook for the UK financial system
    • FinTech and Employee F&F Settlement: How Digital Financial Platforms Are Transforming the Employee Exit Process
    • How AI and Digital Innovation Are Transforming the Future of the FinTech Industry
    • The Power of Ecosystems for Banking
    • The Rise of Fintech: Transforming the Financial Landscape

    ARTICLE

    Sanofi: Information concerning the total number of voting rights and shares - July 2026
    2026-08-13T16:34:47Z
    Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of...


    City of Mobile proclaims Project Persevere Day as The Helios Alliance Reports 117,444 Services Delivered in First Year of Opioid Abatement Program
    2026-08-13T16:15:00Z
    Sixteen organizations delivered 117,444 services at $143.81 per person — among the most efficient deployments of opioid settlement funds nationally — as a public awareness campaign prepares to launch


    Aligned Marketplace Raises $20 Million, Achieves Measurable Outcomes with Large Employers
    2026-08-13T16:00:00Z
    A Third-Party Validated 12 Percent Reduction in Total Cost of Care Delivered in Year One For A Large Fortune 500 Company Proves the Independent Primary Care Model Works at Scale


    Valneva Half-Year 2026 Financial Report
    2026-08-13T15:45:00Z
    Valneva Half-Year 2026 Financial Report


    WellBridge Surgical Named No. 988 on the 2026 Inc. 5000 List, the Most Prestigious Ranking of America’s Fastest-Growing Private Companies
    2026-08-13T15:11:46Z
    Following Significant Revenue Growth Over the Past Three Years, Earning a Place Among the Nation’s Most Successful Independent Businesses


    Tiny Health Named No. 208 on the 2026 Inc. 5000 List of America’s Fastest-Growing Private Companies
    2026-08-13T15:03:13Z
    Microbiome Innovator Recognized for 1,624% Three-Year Revenue Growth, Earning a Place Among the Nation’s Most Successful Independent Businesses


    Invitation to the presentation of ALK’s first six months (Q2) 2026 results on Thursday, 20 August 2026
    2026-08-13T14:06:44Z
    ALK (ALKB:DC / Nasdaq Copenhagen: ALK B) will publish its results for the first six months of 2026 in the morning on Thursday, 20 August 2026.


    Early-Bird Deadline Approaches for 2nd Annual Guardian Initiative Charity Golf Tournament as Veterans Seek Sponsors to Play
    2026-08-13T14:00:00Z
    Players have until August 28 to take advantage of early-bird pricing for the September 28 charity tournament at Maderas Golf Club, while local veterans are seeking sponsors for the opportunity...


    Arisan Therapeutics Selected for NIAID Contract Award to Develop a Therapeutic Small Molecule Viral Entry Inhibitor as a Medical Countermeasure for Filovirus Infection
    2026-08-13T14:00:00Z
    Contract Valued at Up to $24 million Supports IND-Enabling Studies for Arisan’s Lead Candidate with Demonstrated Activity Against Multiple Ebolaviruses


    New MotherToBaby Study Targets Pregnancy Data Gap for Newer Eczema Treatment
    2026-08-13T13:55:00Z
    The FDA has determined that human pregnancy data for Ebglyss® remain insufficient. By enrolling U.S. and Canadian participants, this study will help generate the evidence needed to inform future treatment...


    Acentra Health Awarded Five-Year Contract Extension to Continue Utilization Management Services in Colorado
    2026-08-13T13:33:00Z
    Contract allows state to promote quality and cost-effective healthcare for 1.3 million Coloradans


    Meet Pomoni: Physician-Founded Polyphenol Brand Unveils New Name, New Olive Oil Supplement for Athletes
    2026-08-13T13:15:00Z
    Pomoni debuts Phenolia Endurance,Sponsors Iowa City's core4 Gravel Earth Series race


    OPKO Health Expands Strategic Relationship with HealthCare Royalty Through $125 Million Notes Issuance Secured by Mazdutide Royalty Interests
    2026-08-13T13:15:00Z
    Transaction provides additional non-dilutive capital and enhanced financial flexibility while preserving meaningful long-term royalty upside


    MapLight Therapeutics Announces $150 Million Private Placement Financing 
    2026-08-13T13:10:00Z
    SAN FRANCISCO and BOSTON, Aug. 13, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (Nasdaq: MPLT), a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central...


    CurePSP Establishes Public Policy and Advocacy Team to Accelerate National Impact
    2026-08-13T13:00:00Z
    NEW YORK, Aug. 13, 2026 (GLOBE NEWSWIRE) -- CurePSP has formally established its Public Policy and Advocacy team with the recent additions of Nora Wong, MPH, Associate Director of Public...


    Opción Yo Earns a Place Among the Top 3% of the Inc. 5000
    2026-08-13T12:51:07Z
    MIAMI, FL, Aug. 13, 2026 (GLOBE NEWSWIRE) -- — This recognition reflects a profound cultural shift as more people prioritize emotional well-being with the same intention they have long invested...


    Biofrontera Inc. Reports Strong Second Quarter 2026 Financial Results Driven by 33% Revenue Growth
    2026-08-13T12:51:00Z
    WOBURN, Mass., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ: BFRI) ("Biofrontera" or the "Company"), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT) in...


    SS Innovations Reports Second Quarter 2026 Financial Results
    2026-08-13T12:30:00Z
    Record quarterly revenue driven by continuing strong growth in SSi Mantra unit sales


    Dogwood Therapeutics Announces Second Quarter 2026 Financial Results
    2026-08-13T12:30:00Z
    - Halneuron® Phase 2b trial in Chemotherapy Induced Neuropathy on track for top-line results in fall 2026, 217 patients enrolled –


    PDS Biotech Reports Second Quarter 2026 Financial Results
    2026-08-13T12:30:00Z
    PRINCETON, N.J., Aug. 13, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a clinical-stage biotechnology company focused on developing targeted immunotherapies for cancer, today...


    Fate Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates
    2026-08-13T12:30:00Z
    First lupus nephritis patient dosed in RECLAIM-LN, a Phase 2 potentially registrational trial utilizing FT819, an iPSC-derived, off-the-shelf CAR T-cell therapy; patient was treated as an outpatient with same-day discharge


    Ovid Therapeutics Reports Business Updates and Second Quarter 2026 Financial Results
    2026-08-13T12:30:00Z
    NEW YORK, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to pioneering better, gentler medicines for brain disorders with significant unmet need, today...


    Cingulate Inc. Reports Second Quarter 2026 Financial Results and Provides Update on CTx-1301 CMC Progress Towards NDA Resubmission and Commercial Readiness
    2026-08-13T12:30:00Z
    Cash and Cash Equivalents of $28.4 Million as of June 30, 2026 Providing Runway Through Mid-2027; Company Advances Chemistry, Manufacturing and Controls (CMC) Work Toward NDA Resubmission


    Candel Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
    2026-08-13T12:05:00Z
    NEEDHAM, Mass., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve outcomes for...


    WallabyPhenox Announces First Patient Enrolled in PROMISE Study Evaluating Treatment of Medium Vessel Occlusion Stroke
    2026-08-13T12:00:00Z
    IRVINE, Calif., Aug. 13, 2026 (GLOBE NEWSWIRE) -- WallabyPhenox today announced that the first patient has been enrolled in PROMISE (PROspective study on Management of Ischemic Stroke secondary to mEvo),...


    Artelo Biosciences Provides Business Update and Reports 2026 Second Quarter Financial Results
    2026-08-13T12:00:00Z
    Clinical and Scientific Progress Across the Pipeline Supports Multiple Upcoming Milestones


    Eupraxia Pharmaceuticals Reports Symptom Response Data from its Ongoing Phase 1b/2a RESOLVE Trial, Including New Data on Odynophagia (Painful Swallowing) in Eosinophilic Esophagitis Patients
    2026-08-13T12:00:00Z
    VANCOUVER, British Columbia, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize...


    Grace Therapeutics Announces First Quarter 2027 Financial Results, Provides Business Update
    2026-08-13T12:00:00Z
    PRINCETON, N.J., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage, novel, injectable formulation of...


    Ascentage Pharma to Participate in the Evercore 2nd Annual China Biotech Summit
    2026-08-13T12:00:00Z
    ROCKVILLE, Md., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial-stage, integrated biopharmaceutical company engaged in the...


    Dyadic International, Inc. Secures $2.9 Million Through Registered Direct Offering and Concurrent Private Placement 
    2026-08-13T12:00:00Z
    JUPITER, Fla., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (NASDAQ: DYAI) (the “Company”), d/b/a Dyadic Applied BioSolutions, a biotechnology company developing recombinant protein solutions across the life sciences,...

    Copyright © 2026 | FinTechsDepot | All Rights Reserved |
    Privacy Policy | Unsubscribe
    Sign in

    Welcome, Login to your account.

    Forget password?
    Sign in

    Recover your password.

    A password will be e-mailed to you.